GLYZORLLY-MV 0.2
-&-Voglibose-0.2-mg-Tablets.jpg "GLYZORLLY-MV 0.2")
Gliclazide 80 mg, Metformin 500 mg (SR) & Voglibose 0.2 mg Tablets
Brand :- GLYZORLLY-MV 0.2
Pack Size: 20X10
Pack Type: B/P
Composition:
GLICLAZIDE 80MG + METFORMIN HYDROCHLORIDE 500MG (SR) + VOGLIBOSE 0.2MG TABLETS
Description:
GLYZORLLY-MV 0.2 Tablets are a triple-combination anti-diabetic medication used for the management of Type 2 Diabetes Mellitus. This formulation combines Gliclazide, Metformin (Sustained Release), and Voglibose to provide comprehensive blood sugar control. Gliclazide helps stimulate insulin release from the pancreas, Metformin decreases glucose production in the liver and improves insulin sensitivity, while Voglibose slows down carbohydrate absorption in the intestine, helping control post-meal blood sugar spikes. When used along with proper diet and exercise, this medication helps maintain stable glucose levels and reduces the risk of long-term diabetes-related complications.
Products
-&-Voglibose-0.3-mg-Tablets.jpg "GLYZORLLY-MV 0.3")
-and-Metformin-Hydrochloride-(Sustained-Release)-Tablets.jpg "GLYZORLLY-60M")
-Tablets.jpg "GLIMPZY-MP2 SR")
-Tablets-IP.jpg "GLIMPZY-MF1 500SR")
-Tablets.jpg "GLIMPZY-MF1 1000 SR")
-TABLETS.jpg "GLIMPZY-MF2/1000SR")
-Tablets.jpg "GLIMPZY-MP1 SR")
-Tablets-(450-mg-Diosmin-+-50-mg-Hesperidin).jpg "DAFLOFINE 500 mg")
-Tablets.jpg "DAPAGLYFORD-5M FORTE")
-Tablets.jpg "DAPAGLYFORD-M 10/500SR")
-Tablets.jpg "DAPAGLYFORD-10M FORTE")
-Tablets.jpg "DAPAGLYFORD-GM1 XR")
-Tablets.jpg "DAPAGLYFORD-GM2 XR")
-Tablets.jpg "DAPAGLYFORD-M 5/500SR")
-1000-mg-Tablets.jpg "Sitablast DM Forte")
-500-mg-Tablets.jpg "Sitablast DM")
-Tablets.jpg "SITABLAST-M SR 50/500")
-500-mg,-Glimepiride-1-mg-&-Voglibose-0.3-mg-Tablets.jpg "ORLLYMET-GV 1.3 Billyford")
-1000-mg-Tablets.jpg "Tenoliglipt-M 20/1000")
ORLLYFORD